These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Barnes P, Cox JL, Lappas DG. Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316 [Abstract] [Full Text] [Related]
3. Point-of-care (POC) measurement of coagulation after cardiac surgery. Boldt J, Walz G, Triem J, Suttner S, Kumle B. Intensive Care Med; 1998 Nov; 24(11):1187-93. PubMed ID: 9876982 [Abstract] [Full Text] [Related]
4. Comparison of five point-of-care prothrombin and activated partial thromboplastin time devices based on age of blood sample. Searles B, Nasrallah F, Graham S, Lajara RB. J Extra Corpor Technol; 2002 Sep; 34(3):178-81. PubMed ID: 12395962 [Abstract] [Full Text] [Related]
5. Comparison of bedside coagulation monitoring tests with standard laboratory tests in patients after cardiac surgery. Reich DL, Yanakakis MJ, Vela-Cantos FP, DePerio M, Jacobs E. Anesth Analg; 1993 Oct; 77(4):673-9. PubMed ID: 8214648 [Abstract] [Full Text] [Related]
6. Level of agreement between laboratory and point-of-care prothrombin time before and after cardiopulmonary bypass in cardiac surgery. Meesters MI, Vonk AB, van de Weerdt EK, Kamminga S, Boer C. Thromb Res; 2014 Jun; 133(6):1141-4. PubMed ID: 24703296 [Abstract] [Full Text] [Related]
7. Agreement of point-of-care prothrombin and activated partial thromboplastin time in dogs with a reference laboratory. Yang W, Hosgood G, Luobikis K, Paul A. Aust Vet J; 2018 Oct; 96(10):379-384. PubMed ID: 30255579 [Abstract] [Full Text] [Related]
8. Validation of a point-of-care prothrombin time test after cardiopulmonary bypass in cardiac surgery. Meesters MI, Kuiper G, Vonk AB, Loer SA, Boer C. Anaesthesia; 2016 Oct; 71(10):1163-8. PubMed ID: 27501250 [Abstract] [Full Text] [Related]
9. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs. Tseng LW, Hughes D, Giger U. Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277 [Abstract] [Full Text] [Related]
10. A Comparative Study of Point-of-Care Prothrombin Time in Cardiopulmonary Bypass Surgery. Okabayashi S, Ogawa S, Tanaka KA, Nishiyama T, Takeshita S, Nakayama Y, Nakajima Y, Sawa T, Mizobe T. J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1609-1614. PubMed ID: 29395816 [Abstract] [Full Text] [Related]
11. [Prothrombin time and thromboplastin time. On-site measurement of the prothrombin time and activated partial thromboplastin time of surgical patients with laser photometry]. Tschaikowsky K, Balint R, Pscheidl E, Bremer F. Anaesthesist; 1998 Apr; 47(4):295-302. PubMed ID: 9615846 [Abstract] [Full Text] [Related]
12. Evaluation of a point-of-care coagulation analyzer on patients undergoing cardiopulmonary bypass surgery. Chavez JJ, Weatherall JS, Strevels SM, Liu F, Snider CC, Carroll RC. J Clin Anesth; 2004 Feb; 16(1):7-10. PubMed ID: 14984853 [Abstract] [Full Text] [Related]
13. Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass. Nuttall GA, Oliver WC, Beynen FM, Dull JJ, Murray MJ, Nichols WL. J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):402-9. PubMed ID: 8400094 [Abstract] [Full Text] [Related]
14. Limits of agreement between measures obtained from standard laboratory and the point-of-care device Hemochron Signature Elite(R) during acute haemorrhage. Gauss T, Hamada S, Jurcisin I, Dahmani S, Boudaoud L, Mantz J, Paugam-Burtz C. Br J Anaesth; 2014 Mar; 112(3):514-20. PubMed ID: 24335551 [Abstract] [Full Text] [Related]
15. Determination of normal versus abnormal activated partial thromboplastin time and prothrombin time after cardiopulmonary bypass. Nuttall GA, Oliver WC, Beynen FM, Santrach PJ, Strickland RA, Murray MJ. J Cardiothorac Vasc Anesth; 1995 Aug; 9(4):355-61. PubMed ID: 7579102 [Abstract] [Full Text] [Related]
16. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery. Taneja R, Marwaha G, Sinha P, Quantz M, Stitt L, Gao R, Subramanian S, Schaus M, Keeney M, Chin-Yee I, Murkin J. Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066 [Abstract] [Full Text] [Related]
17. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding. Murray D, Pennell B, Olson J. Transfusion; 1999 Jan; 39(1):56-62. PubMed ID: 9920167 [Abstract] [Full Text] [Related]
18. Comparison between thromboelastography and conventional coagulation tests after cardiopulmonary bypass surgery in the paediatric intensive care unit. Pekelharing J, Furck A, Banya W, Macrae D, Davidson SJ. Int J Lab Hematol; 2014 Aug; 36(4):465-71. PubMed ID: 24325756 [Abstract] [Full Text] [Related]
19. The accuracy of a point of care measurement of activated partial thromboplastin time in intensive care patients. Karigowda L, Deshpande K, Jones S, Miller J. Pathology; 2019 Oct; 51(6):628-633. PubMed ID: 31445807 [Abstract] [Full Text] [Related]
20. Hemorrhage related reexploration following open heart surgery: the impact of pre-operative and post-operative coagulation testing. Hall TS, Sines JC, Spotnitz AJ. Cardiovasc Surg; 2002 Apr; 10(2):146-53. PubMed ID: 11888744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]